-
Posted by
Two Blokes Jun 18 -
Filed in
Stock
-
5 views
Caris Life Sciences' shares jumped nearly 29% in their New York debut on Wednesday, fetching the cancer diagnostic firm a valuation of $7.66 billion and signaling a growing investor appetite for new listings in 2025.
